Every patient receives comprehensive baseline lab work including GH, IGF-1, and metabolic markers, a detailed health history and symptom assessment, individualized peptide selection based on goals and lab results, optimized dosing and administration schedules, ongoing monitoring of GH, IGF-1, and safety markers, regular follow-up to track progress and adjust treatment, and lifestyle guidance to maximize peptide therapy results
Conclusion This meta-analysis suggests that GLP-1RAs, beyond their metabolic benefits, are associated with reduced risks of AUD
In a recent LinkedIn poll conducted in South Africa, many pharmacists reported that the supply of GLP-1 treatments such as Ozempic is still disrupted, making it challenging for diabetic patients to access the medication they need
L.HannappelE.SosneG.KleinmanH
Retatrutide, on the other hand, is still an investigational medication undergoing clinical trials